Regulatory Support
Trusted Experts in Navigating Biologics Regulatory Affairs
Cytovance Biologics has a strong history of regulatory compliance throughout all stages of the product lifecycle. As part of our commitment to a healthier world, patient safety is our primary concern, and we ensure all production processes are designed for optimal clinical and regulatory outcomes.
Aligned for Excellence at Every Phase
Whether it is advising on pre-IND meetings or assisting clients to prepare for chemistry, manufacturing, and controls (CMC) selection, our seasoned quality team has decades of experience in biologics development and manufacturing to successfully guide you through the complex needs of regulatory bodies. Every phase of the manufacturing process comes with regulatory implications, and we know the importance of setting up a strong quality program to ensure compliance at every step on the path to commercial approval and improving patients’ lives.
Navigating the Regulatory Roadmap
The journey through regulatory affairs is often filled with hurdles. At Cytovance, we are poised to assist clients throughout the entire process and position them for regulatory success by offering all critical services for CMC compliance in-house. Our capabilities include manufacturing process validation, quality control release testing, product characterization, and stability testing. We host numerous regulatory and client-driven quality audits each year and can provide you with absolute confidence in our processes and facilities.
Strong Quality Management System
From preclinical to commercially approved phases, our established systems guarantee integrated process control for efficient and reliable project execution. Relying on committed collaboration and communication across all departments, Cytovance’s Quality Management System and MasterControl document solution, strategically and systematically control all activities to ensure that domestic and international quality requirements are fulfilled for your product.
Proven FDA Track Record
Cytovance’s approach to biologics regulatory affairs has been validated through the success of past client programs and FDA audits. Over the years, we have supported 350+ products in clinical trials, 200+ client programs globally, and three commercially approved drug products. We provide procedural and operational excellence across our organization to ensure all relevant regulatory compliances are met so that your product can successfully transition to clinical and commercial stages
Related Areas of Expertise
Process
Characterization
Identification of critical process parameters for a successful
scale-up.
Contact Us
Meet Team Cytovance in 2026!
-
– BIO Investment and Growth Summit: March 2-3, Miami Beach, FL
-
– OPCU Large Molecule: March 24, Virtual
-
– World Vaccine Congress: March 30-April 2, Washington D.C. | Booth 536
– PEGS: May 11-15, Boston, MA -
– TIDES USA Oligonucleotide & Peptide Therapeutics: May 11-14, Boston, MA
-
– BIO International Convention: June 22-25, San Diego, CA | Booth 4445
-
– BioProcess International East: September 22-25, Boston, MA
-
– CPHI Europe: October 6-8, Milan, Italy
-
– CDMO Live Americas: October 19-21, Boston, MA
- – OPCU Large Molecule: October 27, Virtual
